Effects of withdrawing erythropoietin.

This publication has 4 references indexed in Scilit:

• Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group.
  BMJ, 1990
• CHARACTERIZATION OF THE ANEMIA OF CHRONIC RENAL-FAILURE AND THE MODE OF ITS CORRECTION BY A PREPARATION OF HUMAN ERYTHROPOIETIN (R-HUEPO) - AN INVESTIGATION OF THE PHARMACOKINETICS OF INTRAVENOUS ERYTHROPOIETIN AND ITS EFFECTS ON ERYTHROKINETICS
  1989
• Correction of Anaemia of Chronic Renal Failure with Recombinant Human Erythropoietin: Safety and Efficacy of One Year's Treatment in a European Multicentre Study of 150 Haemodialysis-Dependent Patients*
  Nephrology Dialysis Transplantation, 1989
• EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSIS
  The Lancet, 1986